MediciNova Statistics Share Statistics MediciNova has 49.05M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 49.05M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 10.54% Shares Floating 42.08M Failed to Deliver (FTD) Shares 5,624 FTD / Avg. Volume 12.63%
Short Selling Information The latest short interest is 127.51K, so 0.26% of the outstanding
shares have been sold short.
Short Interest 127.51K Short % of Shares Out 0.26% Short % of Float 0.3% Short Ratio (days to cover) 4.62
Valuation Ratios The PE ratio is -9.32 and the forward
PE ratio is -3.26.
MediciNova's PEG ratio is
-0.26.
PE Ratio -9.32 Forward PE -3.26 PS Ratio 0 Forward PS 0.8 PB Ratio 1.96 P/FCF Ratio -9.68 PEG Ratio -0.26
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MediciNova.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.88,
with a Debt / Equity ratio of 0.
Current Ratio 13.88 Quick Ratio 13.88 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-849.97K Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 5.54K Effective Tax Rate -0.05%
Stock Price Statistics The stock price has increased by -35.35% in the
last 52 weeks. The beta is 0.44, so MediciNova's
price volatility has been higher than the market average.
Beta 0.44 52-Week Price Change -35.35% 50-Day Moving Average 1.3 200-Day Moving Average 1.51 Relative Strength Index (RSI) 51.69 Average Volume (20 Days) 44,523
Income Statement
Revenue n/a Gross Profit -21.08K Operating Income -12.68M Net Income -11.05M EBITDA -11.02M EBIT -11.04M Earnings Per Share (EPS) -0.23
Full Income Statement Balance Sheet The company has 40.36M in cash and 193.77K in
debt, giving a net cash position of 40.17M.
Cash & Cash Equivalents 40.36M Total Debt 193.77K Net Cash 40.17M Retained Earnings -426.75M Total Assets 49.82M Working Capital 32.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.64M
and capital expenditures -895, giving a free cash flow of -10.64M.
Operating Cash Flow -10.64M Capital Expenditures -895 Free Cash Flow -10.64M FCF Per Share -0.22
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
